Univariable analyses | Multivariable analyses | |||||
HR | P value | 95% CI | HR | P value | 95% CI | |
Expression of Kif11 | ||||||
High vs low or no expression | 4.592 | 0.001 | 1.937 to 10.891 | 2.782 | 0.022 | 1.162 to 6.664 |
Age (years) | ||||||
≤60 vs >60 | 1.453 | 0.227 | 0.793 to 2.664 | |||
Location | ||||||
Left vs right | 0.720 | 0.293 | 0.391 to 1.328 | |||
Gender | ||||||
Male vs female | 1.114 | 0.739 | 0.589 to 2.109 | |||
Nuclear grade | ||||||
G1 vs G2 vs G3–4 | 2.839 | <0.001 | 1.855 to 4.346 | 2.432 | <0.001 | 1.613 to 3.665 |
Tumour size (cm) | ||||||
≤7 cm vs>7 | 0.727 | 0.299 | 0.398 to 1.327 | |||
PCNA | ||||||
High vs low | 1.815 | 0.067 | 0.959 to 3.437 | |||
TNM stage | ||||||
I vs Ⅱ vs Ⅲ+Ⅳ | 2.571 | <0.001 | 1.69 to 3.90 | 2.32 | 0.001 | 1.440 to 3.737 |
CCRCC, clear cell renal cell carcinoma; Kif11, kinesin family member 11; PCNA, proliferating cell nuclear antigen.